BRIEF-Ironwood, AstraZeneca enter U.S. licensing agreement for lesinurad

* Ironwood Pharmaceuticals enters into U.S. licensing agreement with AstraZeneca for Lesinurad
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.